	US 12,133,906 B2
	Delivery particle
Jiten Odhavji Dihora, Liberty Township, OH (US); Johan Smets, Lubbeek (BE); and Todd Arlin Schwantes, Lena, WI (US)
Assigned to The Procter & Gamble Company, Cincinnati, OH (US)
Filed by The Procter & Gamble Company, Cincinnati, OH (US)
Filed on Aug. 23, 2021, as Appl. No. 17/408,646.
Application 17/408,646 is a continuation of application No. 16/246,568, filed on Jan. 14, 2019, granted, now 11,096,875.
Application 16/246,568 is a continuation of application No. 14/543,432, filed on Nov. 17, 2014, abandoned.
Application 14/543,432 is a continuation of application No. 12/777,301, filed on May 11, 2010, granted, now 9,186,642, issued on Nov. 17, 2015.
Claims priority of provisional application 61/328,949, filed on Apr. 28, 2010.
Prior Publication US 2022/0409497 A1, Dec. 29, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 8/11 (2006.01); A61K 8/81 (2006.01); A61Q 5/02 (2006.01); A61Q 5/12 (2006.01); A61Q 13/00 (2006.01); A61Q 15/00 (2006.01); A61Q 19/00 (2006.01); A61Q 19/10 (2006.01); B01J 13/18 (2006.01); C09B 67/02 (2006.01); C11D 3/37 (2006.01); C11D 3/50 (2006.01); C11D 17/00 (2006.01); D06M 23/12 (2006.01)

CPC A61K 8/11 (2013.01) [A61K 8/8147 (2013.01); A61Q 5/02 (2013.01); A61Q 5/12 (2013.01); A61Q 13/00 (2013.01); A61Q 15/00 (2013.01); A61Q 19/00 (2013.01); A61Q 19/10 (2013.01); B01J 13/185 (2013.01); C09B 67/0097 (2013.01); C11D 3/3757 (2013.01); C11D 3/505 (2013.01); C11D 17/0039 (2013.01); D06M 23/12 (2013.01); A61K 2800/10 (2013.01); A61K 2800/412 (2013.01); A61K 2800/56 (2013.01); A61K 2800/654 (2013.01)]

17 Claims

1. A composition comprising an adjunct ingredient and, based on total composition weight, from about 0.1% to about 50%, of particles, wherein the particles have a median particle size of from about 5 microns to about 56 microns,

wherein the particles comprise:

a) a core comprising, based on total particle weight,

from about 6% to about 99.9% of a benefit agent, wherein the benefit agent comprises perfume, and

from about 0.1% to about 94% of a partitioning modifier comprising an oil soluble material that has a ClogP greater than about 4,

wherein the benefit agent and the partitioning modifier are different materials; and

b) a shell that encapsulates said core, said shell comprising, based on total shell weight, from about 50% to about 100% a polyacrylate,

wherein the polyacrylate is formed, at least in part, from a multifunctional acrylate monomer and/or a multifunctional acrylate oligomer,

wherein the multifunctional acrylate monomer and/or the multifunctional acrylate oligomer is a hexafunctional acrylate oligomer, and

wherein the particles are characterized by a core/shell weight ratio of 80/20 to 90/10.